Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. IGC Pharma Inc. (IGC) Message Board

420 with CNW — Research Finds Marijuana Gives Ro

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 436
(Total Views: 140)
Posted On: 04/28/2023 5:32:21 PM
Avatar
Posted By: NetworkNewsWire
420 with CNW — Research Finds Marijuana Gives Roundworms the Munchies

New research has found that roundworms exposed to marijuana compounds also get the munchies, just like humans. Cannabinoid molecules derived from the marijuana plant usually bind to endocannabinoids, whose receptors are found in the brain, other organs and connective tissues.

Popular cannabinoid molecules include tetrahydrocannabinol (THC), cannabidiol (CBD), cannabinol (CBN), cannabichromene (CBC), cannabigerol (CBG), 9-tetrahydrocannabivarin (THCV), cannabidivarin (CBDV) and cannabivarin (CBV).

The endocannabinoid system is said to balance key bodily functions and regulate functions such as eating, anxiety, memory and sleep.

Researchers found that roundworms, or Caenorhabditis elegans as they are scientifically referred to as, fed for longer than normal while under the influence of marijuana. The worms also demonstrated a higher preference for high-quality foods over less nutritious foods.

The research suggests that the mechanism by which marijuana impacts appetite evolved more than 500 million years ago, when the evolutionary paths of humans and C. elegans diverged. This mutuality across the animal kingdom suggests that these worms could be used to study how marijuana affected the nervous system in humans.

Shawn Lockery, lead author of the study and a neuroscientist at the University of Oregon-Eugene, stated that better understanding basic drug physiology would directly influence societal health as a whole.

The researchers were motivated to conduct the experiments after the state of Oregon legalized adult-use marijuana. For their study, the scientists divided the worms into two groups then submerged one group in a solution of the endocannabinoid anandamide before placing them in the maze.

They observed that the worms developed bigger appetites, noting that in the maze, these worms mainly preferred higher quality foods, in addition to spending more time eating. Roundworms that were plunged in the solution also demonstrated less interest in bacteria that was nutritionally inferior, with researchers noting that these effects were pronounced in worms with working endocannabinoid receptors.

In separate experiments, the scientists tested endocannabinoids on worms with genetically engineered human cannabinoid receptors.

They observed that the worms responded in a similar way, with the scientists highlighting that the cannabinoids affected the worms’ food-detecting olfactory neurons, making them more sensitive to the odors of preferred bacteria.

Prior studies have demonstrated that cannabinoids cause hedonic hunger in other mammals such as primates and rats.

This latest research calls attention to similarities suggesting that Caenorhabditis elegans could offer a cost-effective way to model how compounds derived from marijuana affect the nervous system in humans.

The study reported its findings in the “Current Biology1” journal.

Plenty of research is currently ongoing, with enterprises such as IGC Pharma Inc. (NYSE American: IGC) setting their sights on having FDA-approved formulations on the market to help patients with different ailments.

NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer



(0)
(0)




IGC Pharma Inc. (IGC) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us